44,870 reports of this reaction
12.5% of all LEVONORGESTREL reports
#1 most reported adverse reaction
DEVICE EXPULSION is the #1 most commonly reported adverse reaction for LEVONORGESTREL, manufactured by Bayer HealthCare Pharmaceuticals Inc.. There are 44,870 FDA adverse event reports linking LEVONORGESTREL to DEVICE EXPULSION. This represents approximately 12.5% of all 357,584 adverse event reports for this drug.
Patients taking LEVONORGESTREL who experience device expulsion should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE EXPULSION is a frequently reported adverse event for LEVONORGESTREL, accounting for a significant proportion of all reports.
In addition to device expulsion, the following adverse reactions have been reported for LEVONORGESTREL:
The following drugs have also been linked to device expulsion in FDA adverse event reports:
DEVICE EXPULSION has been reported as an adverse event in 44,870 FDA reports for LEVONORGESTREL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE EXPULSION accounts for approximately 12.5% of all adverse event reports for LEVONORGESTREL, making it one of the most commonly reported side effect.
If you experience device expulsion while taking LEVONORGESTREL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.